Efficacy of combined orbital radiation and systemic steroids in the management of Graves’ orbitopathy

2016 ◽  
Vol 254 (5) ◽  
pp. 991-998 ◽  
Author(s):  
Ji Won Kim ◽  
Sun Hyup Han ◽  
Byeong Jae Son ◽  
Tyler Hyungtaek Rim ◽  
Ki Chang Keum ◽  
...  
2016 ◽  
Vol 171 ◽  
pp. 11-17 ◽  
Author(s):  
Ji Won Kim ◽  
Ka Hyun Lee ◽  
Young Jun Woo ◽  
Jinna Kim ◽  
Ki Chang Keum ◽  
...  

2018 ◽  
Vol 127 ◽  
pp. S625-S626
Author(s):  
R. Carmona-Vigo ◽  
I. San Miguel Arregui ◽  
L. Luque Japón ◽  
P.C. Lara Jiménez

2001 ◽  
Vol 120 (5) ◽  
pp. A749-A749
Author(s):  
A CORTOT ◽  
J COLOMBEL ◽  
P RUTGEERTS ◽  
K LAURITSEN ◽  
H MALCHOW ◽  
...  

2010 ◽  
Vol 43 (20) ◽  
pp. 66
Author(s):  
MICHELE G. SULLIVAN
Keyword(s):  

2018 ◽  
Author(s):  
Asimi Zelija Velija ◽  
Azra Burekovic ◽  
Amela Dizdarevic-Bostandzic ◽  
Amina Godinjak ◽  
Amela Tuco

2020 ◽  
Author(s):  
Georgios Boutzios ◽  
Sofia Kouvelioti ◽  
Eleni Papaoiconomou ◽  
Eleni Koukoulioti ◽  
Myrto Miliou ◽  
...  

2020 ◽  
Author(s):  
Ricardo Firme ◽  
Pedro Morato ◽  
Luiza Morato ◽  
Julia Morato
Keyword(s):  

2014 ◽  
Vol 155 (33) ◽  
pp. 1295-1300
Author(s):  
Annamária Erdei ◽  
Annamária Gazdag ◽  
Miklós Bodor ◽  
Eszter Berta ◽  
Mónika Katkó ◽  
...  

Graves’ orbitopathy is the most common extrathyroidal manifestation of Graves’ disease. Up to now, curative treatment modalities for the most severe sight-threatening cases have not been developed. Here the authors summarize the treatment protocol of Graves’ orbitopathy and review novel therapeutic options. They review the literature on this topic and present their own clinical experience. The authors point out that anti-CD20 antibody could positively influence the clinical course of Graves’ orbitopathy. Selenium is efficient in mild cases. Further prospective investigations are warranted. Orv. Hetil., 2014, 155(33), 1295–1300.


Sign in / Sign up

Export Citation Format

Share Document